Annals of Oncology 14:967, 2003
© 2003 European Society for Medical Oncology
An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
Ann Oncol2003; 14: 520535
Figure 2 on page 521 of the above mentioned article was created by Dr Antonio Grillo-Lopez of IDEC Pharmaceuticals Corp. in his work involving Rituximab® (rituximab). Dr Grillo-Lopez was the Chief Medical Officer at IDEC Pharmaceuticals (19922001) until his retirement from that company in 2001. The graph is the copyrighted work of IDEC Pharmaceuticals Corp., and should have included the following notice:
©1992 IDEC Pharmaceutical Corp. Reprinted with permission from the copyright owner. All rights reserved.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||